The post Lighter Leads Perp DEX 24-Hour Volume as EdgeX Overtakes Hyperliquid; On-Chain Liquidity Remains Sluggish appeared on BitcoinEthereumNews.com. As of DecemberThe post Lighter Leads Perp DEX 24-Hour Volume as EdgeX Overtakes Hyperliquid; On-Chain Liquidity Remains Sluggish appeared on BitcoinEthereumNews.com. As of December

Lighter Leads Perp DEX 24-Hour Volume as EdgeX Overtakes Hyperliquid; On-Chain Liquidity Remains Sluggish

As of December 26, DefiLlama data show that 24-hour trading volume across mainstream perp DEXs remains subdued and on-chain liquidity has not yet recovered. Lighter leads in activity, with EdgeX overtaking Hyperliquid for second place. Key figures: Lighter ~$47.5B vol, $13.9B TVL, $15.1B OI; EdgeX ~$27.7B vol, $3.65B TVL, $7.42B OI; Hyperliquid ~$24.5B vol, $41.3B TVL, $70.9B OI.

Other notable venues include Aster (~$20.6B vol, $12.7B TVL, $24.2B OI), ApeX (~$15.9B, $46.35M TVL, $2.59B OI), Variational (~$10.9B, $66.18M TVL, $4.85B OI), Backpack (~$8.13B vol; TVL undisclosed; $2.16B OI), and Pacifica (~$6.5B vol, $41.36M TVL, $61.9M OI). Overall, on-chain liquidity remains uneven, signaling cautious liquidity management in DeFi derivatives.

Source: https://en.coinotag.com/breakingnews/lighter-leads-perp-dex-24-hour-volume-as-edgex-overtakes-hyperliquid-on-chain-liquidity-remains-sluggish

Market Opportunity
Perpetual Protocol Logo
Perpetual Protocol Price(PERP)
$0.09427
$0.09427$0.09427
-0.29%
USD
Perpetual Protocol (PERP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.